What the Science Really Tells Us
By Dr. John A. Robinson, NMD
Introduction
For decades, physicians believed that frequent sexual activity might somehow increase a man’s risk of developing prostate cancer. Like many ideas in medicine, that assumption became accepted long before we truly understood the biology behind it. As our understanding of prostate physiology has evolved, however, so has the research. Today, we find ourselves asking a very different question. Rather than wondering whether ejaculation is harmful, researchers have begun investigating whether maintaining normal sexual function may actually contribute to a healthier prostate throughout life.
One of the lessons that has become increasingly important to me over more than twenty years of practicing medicine is that the body generally rewards normal physiology. We spend an enormous amount of time searching for new medications, procedures, and technologies to improve health, yet we sometimes overlook the possibility that many of the body’s natural functions exist because they serve an important biologic purpose. Sexual function may be one of those examples. While I would never suggest that ejaculation is a treatment for prostate cancer, I do believe the available evidence provides a fascinating glimpse into how the prostate was designed to function and why preserving normal physiology may be one component of maintaining long-term prostate health.
The Research Has Become Increasingly Convincing
The strongest evidence we have comes from one of the largest and longest studies ever performed on this subject. Researchers from Harvard University followed 31,925 men enrolled in the Health Professionals Follow-up Study for approximately 18 years, evaluating their ejaculation frequency during different decades of adulthood and comparing those habits with the subsequent development of prostate cancer.
Their original findings, published in JAMA in 2004, challenged conventional thinking by demonstrating that men who ejaculated more frequently appeared to have a lower risk of prostate cancer. More importantly, those findings were strengthened over the following decade. An updated analysis published in European Urology in 2016 confirmed the association after an additional ten years of follow-up, making it one of the most comprehensive investigations of prostate health ever performed.
The results were remarkably consistent. Men who reported ejaculating 21 or more times per month experienced approximately a 20% to 22% lower risk of developing prostate cancer than men who ejaculated only four to seven times each month. Depending upon the statistical model and subgroup analyzed, some data suggested the reduction in risk approached 30 to 31 percent. Even after accounting for age, body weight, physical activity, diet, smoking, alcohol use, prostate-specific antigen (PSA) screening, and numerous other lifestyle factors, the association remained significant.
As physicians, we always have to be careful when interpreting observational studies. Correlation is not causation, and these studies cannot prove that ejaculation itself prevents prostate cancer. Nevertheless, when nearly thirty-two thousand men are followed for almost two decades and the same pattern continues to emerge, it deserves our attention. The consistency of the findings suggests that we are observing something biologically meaningful rather than a statistical coincidence.
Understanding the Biology of the Prostate
Whenever I encounter research like this, I find myself asking a simple question:Â How was this organ designed to function?
The prostate is not simply a gland that enlarges as men age or one that occasionally develops cancer. It is an active secretory organ whose primary responsibility is producing the fluid that nourishes, protects, and transports sperm. Throughout a man’s life, prostate cells continually manufacture proteins, enzymes, zinc-rich secretions, citrate, and numerous other biologically active compounds that become part of seminal fluid.
Like virtually every gland in the body, the prostate was designed to remain active. It was not intended to become stagnant.
I often compare this concept to the difference between a flowing stream and a stagnant pond. Water that continues to move generally remains healthier than water that sits motionless, allowing debris and contaminants to accumulate over time. Although the prostate is obviously far more sophisticated than a stream, the analogy illustrates an important principle of biology. Organs that are designed to function regularly often remain healthier when they are allowed to perform the tasks for which they were created.
The prostate is also an organ with an extraordinarily high metabolic demand. It continuously produces secretions, remodels tissue, responds to hormones, communicates with immune cells, and repairs itself throughout life. Any disruption in those processes has the potential to alter the microenvironment within the gland.
The “Stagnation Theory”
One of the leading explanations proposed by researchers is commonly referred to as the prostate stagnation theory. Although it remains a hypothesis rather than an established fact, I believe it makes physiologic sense.
The theory suggests that regular ejaculation helps empty the prostatic ducts and clear accumulated secretions before inflammatory compounds, oxidative metabolites, or potentially carcinogenic substances have an opportunity to remain within the gland for prolonged periods. Some investigators have proposed that frequent drainage may reduce exposure of prostate cells to substances capable of promoting chronic inflammation or DNA damage.
The Urology Care Foundation has described this concept as a type of biologic “flushing” mechanism. Just as tears protect the eyes and saliva protects the mouth, normal prostatic secretions may serve protective functions that are enhanced when the gland continues to function as intended.
Of course, we must acknowledge the limitations of this theory. No study has directly demonstrated that ejaculation physically removes carcinogens from the prostate or that doing so is the precise reason prostate cancer risk appears lower. Biology is rarely that simple. However, when viewed alongside what we know about glandular physiology, inflammation, oxidative stress, and tissue homeostasis, the hypothesis is certainly plausible.
One of the principles of regenerative medicine is that normal physiology generally exists for a reason. The more we understand the body’s design, the more we appreciate that many functions we once considered incidental may actually serve protective purposes.
Inflammation Is Almost Always Part of the Story
If there is one lesson that has been reinforced throughout my career, it is that chronic inflammation lies at the center of nearly every chronic disease we encounter. Whether we are discussing cardiovascular disease, diabetes, Alzheimer’s disease, arthritis, obesity, or cancer, inflammation repeatedly emerges as one of the common pathways that accelerates aging and tissue dysfunction.
The prostate is no exception.
Chronic inflammation within the prostate has been associated with benign prostatic enlargement, chronic prostatitis, urinary symptoms, and potentially the development of malignancy. Persistent inflammatory signaling exposes tissues to oxidative stress, increases DNA damage, disrupts mitochondrial function, and alters normal cellular communication. Molecules such as IL-6, TNF-α, NF-κB, and reactive oxygen species contribute to an environment in which normal repair mechanisms become less efficient and abnormal cellular behavior becomes more likely.
One of the reasons I find the ejaculation studies so interesting is not because they identify a specific number of ejaculations each month, but because the findings fit remarkably well with what we already understand about chronic inflammation. Anything that supports healthy tissue turnover, maintains normal glandular function, and reduces chronic inflammatory burden deserves thoughtful consideration.
The Prostate Does Not Exist in Isolation
One of the greatest mistakes we make in medicine is treating the prostate as though it exists independently from the rest of the body. It doesn’t.
The prostate responds continuously to hormones, metabolism, immune function, circulation, endothelial health, mitochondrial function, sleep quality, psychological stress, and countless molecular signals that are communicating every second of every day. When one of these systems becomes dysfunctional, the others inevitably follow.
In my practice, declining sexual function is often one of the earliest warning signs that something much larger is developing. Low testosterone, insulin resistance, visceral obesity, endothelial dysfunction, chronic inflammation, sleep apnea, depression, and chronic stress frequently appear long before a man develops significant prostate disease. These same conditions also increase the risk of cardiovascular disease, diabetes, cognitive decline, and accelerated aging.
That is why I never evaluate the prostate in isolation. Healthy organs rarely exist independently. The body functions as an integrated ecosystem, and every system influences every other system.
What About Testosterone?
Whenever prostate health is discussed, testosterone inevitably becomes part of the conversation. For decades physicians were taught that testosterone “feeds” prostate cancer, leading many men to avoid hormone replacement therapy out of fear.
Today, our understanding has changed dramatically.
Modern research, including the work of Dr. Abraham Morgentaler and others, has challenged the traditional belief that restoring testosterone to normal physiologic levels inevitably increases prostate cancer risk. The Saturation Model proposes that prostate tissue becomes maximally stimulated at relatively low androgen concentrations, meaning that increasing testosterone within the normal physiologic range does not continue to proportionally stimulate prostate growth or cancer development.
This aligns closely with what I have observed throughout my own clinical practice. Appropriate testosterone replacement, performed responsibly with careful monitoring, has not demonstrated the catastrophic effects that many physicians once feared. In fact, low testosterone itself has been associated in several studies with more aggressive prostate cancer, poorer metabolic health, increased inflammation, sarcopenia, insulin resistance, and increased cardiovascular risk.
That does not mean testosterone therapy is appropriate for every man, nor does it eliminate the need for PSA monitoring and individualized screening. It simply reminds us that hormone physiology is far more sophisticated than we once believed.
The prostate does not respond to testosterone alone. It responds to an extraordinarily complex environment involving testosterone, dihydrotestosterone, estradiol, insulin, cortisol, inflammatory cytokines, growth factors, mitochondrial health, immune surveillance, vascular function, and countless signaling molecules communicating continuously throughout the body.
Human physiology is governed by balance, not by isolated hormones.
What Should Men Actually Do?
Whenever patients read research like this, the first question they ask is usually, “So what should I actually do?”
My answer is always the same. Focus on building the healthiest internal environment possible.
Maintain lean muscle mass through regular resistance training. Prioritize adequate dietary protein. Reduce visceral fat. Exercise consistently. Sleep seven to eight hours each night whenever possible. Address chronic stress before it becomes chronic disease. Follow an anti-inflammatory dietary pattern rich in vegetables, healthy fats, and omega-3 fatty acids. Avoid smoking. Limit excessive alcohol intake. Optimize hormone balance when appropriate. Monitor metabolic health through fasting insulin, glucose control, body composition, and cardiovascular risk factors.
Equally important is appropriate prostate screening. PSA testing, free PSA, prostate MRI when indicated, family history assessment, and individualized discussions with your physician remain essential components of preventive care. These strategies work together because health is never created by a single habit or a single intervention.
My Perspective
After more than twenty years of caring for men, I have become convinced that the prostate is one of the most misunderstood organs in the human body. We tend to think about it only after it becomes enlarged or cancer develops, yet the prostate reflects the health of the entire individual. It responds to hormones, metabolism, immune function, circulation, inflammation, mitochondrial health, and countless molecular signals that are continually communicating with one another. When I help a patient reduce inflammation, improve metabolic health, optimize hormones, build lean muscle, improve sleep, preserve cardiovascular function, and strengthen the relationships that give life meaning, I am not simply improving one organ. I am creating the biologic environment in which every tissue—including the prostate—has the opportunity to function as it was designed.
That is why I find the research on ejaculation frequency so fascinating. It is not because it identifies a magic number or offers a simple prescription for preventing prostate cancer. Rather, it reinforces a principle that has only grown stronger throughout my career. The human body evolved extraordinarily sophisticated systems for maintaining health long before physicians, hospitals, pharmaceuticals, or modern technology existed. Our role is not to override those systems but to understand them, support them, and remove the obstacles that prevent them from functioning optimally.
Whether I am discussing hormones, regenerative medicine, cardiovascular disease, musculoskeletal health, or prostate health, my philosophy remains exactly the same. Healing is not something we create. Healing is something we cultivate. The more deeply I study human physiology, the more convinced I become that longevity is achieved not by fighting biology but by understanding biology and creating the conditions in which it can perform the remarkable work it has been doing since long before medicine ever existed.
References
- Rider JR, Wilson KM, Sinnott JA, et al. Ejaculation Frequency and Risk of Prostate Cancer: Updated Results with an Additional Decade of Follow-up. European Urology. 2016;70(6):974-982.
- Leitzmann MF, Platz EA, Stampfer MJ, Willett WC, Giovannucci E. Ejaculation Frequency and Subsequent Risk of Prostate Cancer. JAMA. 2004;291(13):1578-1586.
- Harvard Health Publishing. Ejaculation frequency and prostate cancer.
- Urology Care Foundation. Prostate Cancer Patient Education Resources.
